# FDA Inspection 1243909 - Zhejiang Jingxin Pharmaceutical Co., Ltd. - June 21, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-jingxin-pharmaceutical-co-ltd/4be10b97-bfbf-420a-906d-79f590d2e065
Source feed: FDA_Inspections

> FDA Inspection 1243909 for Zhejiang Jingxin Pharmaceutical Co., Ltd. on June 21, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243909
- Company Name: Zhejiang Jingxin Pharmaceutical Co., Ltd.
- Inspection Date: 2024-06-21
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1290202 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/zhejiang-jingxin-pharmaceutical-co-ltd/57dddb9e-134f-4ff1-8630-0b0f65b6729e)

Company: https://www.keypedia.com/companies/zhejiang-jingxin-pharmaceutical-co-ltd/ab00cf21-af67-4184-bd55-ffdc1105b98a

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8